BMI and Differential Epithelial and Stromal ER/PR Expression within Type I and Type II Endometrial Carcinoma

被引：0
|
作者：
Peevey, Joseph [1 ]
Maniar, Kruti P. [1 ]
Kim, Ji-Yong Julie [1 ]
机构：
[1] Northwestern Mem Hosp, Chicago, IL USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1219
引用
收藏
页码：304A / 304A
页数：1
相关论文
共 50 条
  • [41] Endometrial Stromal Expression of ER, PR, and B-Catenin Toward Differentiating Hyperplasia Diagnoses
    Chatzipantelis, Paschalis
    Koukourakis, Michail
    Balaska, Konstantina
    Giatromanolaki, Alexandra
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2022, 30 (05) : 492 - 498
  • [42] Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma
    Guerra, Flora
    Kurelac, Ivana
    Cormio, Antonella
    Zuntini, Roberta
    Amato, Laura Benedetta
    Ceccarelli, Claudio
    Santini, Donatella
    Cormio, Gennaro
    Fracasso, Flavio
    Selvaggi, Luigi
    Resta, Leonardo
    Attimonelli, Marcella
    Gadaleta, Maria Nicola
    Gasparre, Giuseppe
    HUMAN MOLECULAR GENETICS, 2011, 20 (12) : 2394 - 2405
  • [43] Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas
    Pansare, Vaishali
    Munkarah, Adnan R.
    Schimp, Veronica
    Arabi, M. Haitham
    Saed, Ghassan M.
    Morris, Robert T.
    Ali-Fehmi, Rouba
    MODERN PATHOLOGY, 2007, 20 (01) : 35 - 43
  • [44] Should Endometrial Clear Cell Carcinoma be Classified as Type II Endometrial Carcinoma?
    Bae, Hyo Sook
    Kim, Hyesun
    Kwon, Sun Young
    Kim, Kyu-Rae
    Song, Jae Yun
    Kim, Insun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2015, 34 (01) : 74 - 84
  • [45] Immunohistochemical Expression of ERα, ERβ, and TFF1 in Type I and II Ovarian Tumors
    Abdou, Asmaa G.
    Aiad, Hayam A.
    Asaad, Nancy Y.
    Abd El-Wahed, Moshira M.
    El-Dien, Marwa Serag
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (06) : 421 - 432
  • [46] Hysteroscopic and immunohistochemical findings in type I and type II endometrial carcinomas
    Maia, H
    Maltez, A
    Fahel, P
    Coutinho, E
    JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS, 2001, 8 (02): : 222 - 230
  • [47] Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
    Alicia Beeghly-Fadiel
    Andrew J. Wilson
    Spencer Keene
    Meral El Ramahi
    Shu Xu
    Lawrence J. Marnett
    Oluwole Fadare
    Marta A. Crispens
    Dineo Khabele
    Journal of Ovarian Research, 11
  • [48] Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
    Beeghly-Fadiel, Alicia
    Wilson, Andrew J.
    Keene, Spencer
    El Ramahi, Meral
    Xu, Shu
    Marnett, Lawrence J.
    Fadare, Oluwole
    Crispens, Marta A.
    Khabele, Dineo
    JOURNAL OF OVARIAN RESEARCH, 2018, 11
  • [49] EXPRESSION OF ER, PR AND HER-2/NEU IN ENDOMETRIAL CARCINOMA - A CLINICOPATHOLOGICAL STUDY
    Kaur, J.
    Suri, A.
    Kaur, M.
    Bal, M. S.
    Kaur, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1549 - 1549
  • [50] Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma
    Liang, Yanfang
    Lin, Bihua
    Ye, Ziyu
    Chen, Shasha
    Yu, Haibo
    Chen, Can
    Zhang, Xin
    Zhou, Keyuan
    Zeng, Jincheng
    JOURNAL OF CANCER, 2020, 11 (06): : 1436 - 1445
12345